Results 211 to 220 of about 629,571 (311)

Recruitment strategies and participant motivations in a digital randomized controlled trial for the prevention of anxiety disorders: the prevANS study. [PDF]

Front Digit Health
García-Huércano C, Conejo-Cerón S, Rodríguez-Morejón A, Martínez-Vispo C, Sánchez-Aguadero N, Tamayo-Morales O, Moreno-Peral P.   +6 more
europepmc   +1 more source

Evaluation of the effect of implant-supported fixed prostheses on patients' quality of life and anxiety disorders. [PDF]

BMC Oral Health
Kuşçu Aİ, Sarıkaya I.
europepmc   +1 more source

Descriptive Epidemiology From the Myhre Syndrome Foundation Registry: The Value of Self‐Reported Data

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre syndrome is an ultrarare genetic disease characterized by short stature, distinct craniofacial features, cardiovascular and respiratory fibrosis and stenosis, neurodevelopmental delays, autism, intellectual disability, and hearing loss. The natural history of Myhre syndrome is still not fully understood due to a small patient population ...
Mary K. Young, Armelle Pindon, Maggie R. Brand, Kate Wears, Katherine H. Young, Alyssa Mendel, Michael J. Lyons   +6 more
wiley   +1 more source

Comparative Efficacy of Exercise Interventions for Anxiety Disorders: A Bayesian Network Meta-Analysis. [PDF]

Psychol Res Behav Manag
Liu J, Wang H, Lan Y, Yuan D, Du B, Zhou Y, Zhang W, Ke XW, Jiang Q, Wang F, Cao S, Sun J.   +11 more
europepmc   +1 more source

Review of the Molecular and Developmental Basis of Myhre Syndrome, Bench Research

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre syndrome (MS) is a connective‐tissue disorder within the acromelic dysplasia spectrum. It is characterized by congenital craniofacial, skeletal, cutaneous anomalies, respiratory, cardiovascular along with intellectual disability, deafness, and progressive fibrosis.
Camille Viaut, Valerie Cormier‐Daire
wiley   +1 more source

Longitudinal changes in cardiorespiratory fitness and risk of depressive and anxiety disorders in a nationwide cohort of 7 million participants. [PDF]

Sci Rep
Park JH, Kong S, Lim Y, Oh Y, Chawanid P, Gökbulut B, Kim JW, Park SJ, Kim HJ, Cheon S, Kang ES, Jang S, Lee J, Kang M, Kwak T, Kim Y, Song J, Khil J, Lee SK, Kim JM, Jeong S, Lee H.   +21 more
europepmc   +1 more source

The EXPLAIN Study: Exploring Arthrogryposis Multiplex Congenita in Adults in Norway — A Description of Demographic, Medical, and Neurological Findings

American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Arthrogryposis Multiplex Congenita (AMC) encompasses several hundred conditions with diverse genetic, pathophysiological, and clinical origins. The overarching EXPLAIN study explores underlying causes and implications of AMC and represents the largest clinical cohort of adults with AMC reported to date.
My Vuong Hermansen, Kristin Ørstavik, Unni Steen, Mathias Toft, Cathrine Brunborg, Lena Lande Wekre   +5 more
wiley   +1 more source

Risk of Mood and Anxiety Disorders in the Postpartum Period Following Assisted Reproduction: A Retrospective Cohort Study. [PDF]

Health Sci Rep
Imbroane MR, Kim H, Richards EG.
europepmc   +1 more source

Measuring Child Disadvantage: Comparing Multidimensional and Socioeconomic Approaches for Predicting Developmental Outcomes

Australian Journal of Social Issues, EarlyView.
ABSTRACT Robust measurement of disadvantage is essential to identifying and addressing inequities in children's development. We tested how a multidimensional framework of child disadvantage performed relative to a traditional socioeconomic position (SEP) approach to predict developmental outcomes.
Wei Hong, Fiona Mensah, Elodie O'Connor, Shuaijun Guo, Sharon Goldfeld, Meredith O'Connor, Cindy Pham, Sarah Gray   +7 more
wiley   +1 more source

The Onset, Course and Co-Occurrence of Depressive and Anxiety Disorders Over a 9-Year Period in the General Population. [PDF]

Int J Methods Psychiatr Res
Ten Have M, Tuithof M, Velek P, Van Dorsselaer S, Korteling S, Penninx BWJH, Luik AI.   +6 more
europepmc   +1 more source